Tech Company Financing Transactions
AbGenomics Funding Round
AbGenomics closed a $9.6 million funding round on 7/19/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
7/19/2013
Transaction Type
Venture Equity
Amount
$9,600,000
Round
Undisclosed
Investors
Proceeds Purpose
AbGenomics will use the proceeds to continue advancing its therapeutic antibodies for autoimmune diseases and cancers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4966 El Camino Real 200
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Undisclosed
Website
Email Address
Overview
AbGenomics is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronghwa Lin
Chief Medical Officer
Shih-Yao Lin
Controller
Crystal Lin
Vice President
Hazel Cheng
VP - Administration
Leewen Lin
VP - Bus. Development
Joseph McCracken
VP - Finance
Hsiao-Wen Tuan
Browse more venture capital transactions:
Prev: 7/19/2013: KISSmetrics venture capital transaction
Next: 7/19/2013: Nifti venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs